• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障通透性纳米颗粒通过选择性诱导小胶质细胞自噬治疗阿尔茨海默病。

Blood-brain barrier Permeable nanoparticles for Alzheimer's disease treatment by selective mitophagy of microglia.

机构信息

Department of Neurology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China; Center for Materials Synthetic Biology, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.

Department of Neurology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China.

出版信息

Biomaterials. 2022 Sep;288:121690. doi: 10.1016/j.biomaterials.2022.121690. Epub 2022 Aug 12.

DOI:10.1016/j.biomaterials.2022.121690
PMID:35965114
Abstract

Current treatments for Alzheimer's disease (AD) that focus on inhibition of Aβ aggregation failed to show effectiveness in people who already had Alzheimer's symptoms. Strategies that synergistically exert neuroprotection and alleviation of oxidative stress could be a promising approach to correct the pathological brain microenvironment. Based on the key roles of microglia in modulation of AD microenvironment, we describe here the development of Prussian blue/polyamidoamine (PAMAM) dendrimer/Angiopep-2 (PPA) nanoparticles that can regulate the mitophagy of microglia as a potential AD treatment. PPA nanoparticles exhibit superior blood-brain barrier (BBB) permeability and exert synergistic effects of ROS scavenging and restoration of mitochondrial function of microglia. PPA nanoparticles effectively reduce neurotoxic Aβ aggregate and rescue the cognitive functions in APP/PS1 model mice. Together, our data suggest that these multifunctional dendrimer nanoparticles exhibit efficient neuroprotection and microglia modulation and can be exploited as a promising approach for the treatment of AD.

摘要

目前针对阿尔茨海默病(AD)的治疗方法侧重于抑制 Aβ 聚集,但在已经出现阿尔茨海默病症状的人群中并未显示出有效性。协同发挥神经保护和减轻氧化应激作用的策略可能是纠正病理性脑微环境的一种有前途的方法。基于小胶质细胞在调节 AD 微环境中的关键作用,我们在这里描述了普鲁士蓝/聚酰胺胺(PAMAM)树枝状大分子/血管生成肽-2(Angiopep-2,PPA)纳米粒子的开发,该纳米粒子可以调节小胶质细胞的自噬作为一种潜在的 AD 治疗方法。PPA 纳米粒子表现出优异的血脑屏障(BBB)通透性,并发挥 ROS 清除和恢复小胶质细胞线粒体功能的协同作用。PPA 纳米粒子可有效减少神经毒性 Aβ 聚集物,并挽救 APP/PS1 模型小鼠的认知功能。总之,我们的数据表明,这些多功能树枝状大分子纳米粒子具有有效的神经保护和小胶质细胞调节作用,可作为治疗 AD 的一种有前途的方法。

相似文献

1
Blood-brain barrier Permeable nanoparticles for Alzheimer's disease treatment by selective mitophagy of microglia.血脑屏障通透性纳米颗粒通过选择性诱导小胶质细胞自噬治疗阿尔茨海默病。
Biomaterials. 2022 Sep;288:121690. doi: 10.1016/j.biomaterials.2022.121690. Epub 2022 Aug 12.
2
Biofilm-camouflaged Prussian blue synergistic mitochondrial mass enhancement for Alzheimer's disease based on Cu chelation and photothermal therapy.基于铜螯合和光热疗法的生物膜伪装普鲁士蓝协同增强线粒体质量治疗阿尔茨海默病
J Control Release. 2024 Nov;375:269-284. doi: 10.1016/j.jconrel.2024.09.009. Epub 2024 Sep 13.
3
Multifunctional Nanocarrier for Synergistic Treatment of Alzheimer's Disease by Inhibiting β-Amyloid Aggregation and Scavenging Reactive Oxygen Species.用于通过抑制β-淀粉样蛋白聚集和清除活性氧协同治疗阿尔茨海默病的多功能纳米载体
ACS Appl Mater Interfaces. 2024 May 29;16(21):27127-27138. doi: 10.1021/acsami.4c02825. Epub 2024 May 15.
4
Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.涂覆有高血脑屏障通透性肽-B6肽的唾液酸(SA)修饰的硒纳米颗粒,用于阿尔茨海默病的潜在应用。
Acta Biomater. 2015 Oct;25:172-83. doi: 10.1016/j.actbio.2015.06.035. Epub 2015 Jul 2.
5
Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.纤维状 Aβ 在阿尔茨海默病小鼠模型中引发小胶质细胞蛋白质组改变和功能障碍。
Elife. 2020 Jun 8;9:e54083. doi: 10.7554/eLife.54083.
6
Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.小胶质细胞通过抑制神经胶质淋巴清除来防止阿尔茨海默病小鼠模型早期β-淀粉样斑块的形成。
Alzheimers Res Ther. 2020 Oct 2;12(1):125. doi: 10.1186/s13195-020-00688-1.
7
Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.小胶质细胞 CX3CR1 杂合缺失恢复神经元 β-淀粉样蛋白清除途径并减缓 PS1-APP 小鼠阿尔茨海默病样疾病的进展。
Front Immunol. 2019 Dec 2;10:2780. doi: 10.3389/fimmu.2019.02780. eCollection 2019.
8
Haploinsufficiency of microglial MyD88 ameliorates Alzheimer's pathology and vascular disorders in APP/PS1-transgenic mice.小胶质细胞 MyD88 单倍不足可改善 APP/PS1 转基因小鼠的阿尔茨海默病病理和血管紊乱。
Glia. 2021 Aug;69(8):1987-2005. doi: 10.1002/glia.24007. Epub 2021 May 2.
9
Tissue-Plasminogen Activator Attenuates Alzheimer's Disease-Related Pathology Development in APPswe/PS1 Mice.组织型纤溶酶原激活剂可减轻APPswe/PS1小鼠中与阿尔茨海默病相关的病理发展。
Neuropsychopharmacology. 2016 Apr;41(5):1297-307. doi: 10.1038/npp.2015.279. Epub 2015 Sep 9.
10
Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.二氢杨梅素通过抑制 APP/PS1 转基因小鼠中 NLRP3 炎性小体的激活来抑制小胶质细胞的激活和神经炎症。
CNS Neurosci Ther. 2018 Dec;24(12):1207-1218. doi: 10.1111/cns.12983. Epub 2018 Jun 4.

引用本文的文献

1
Ceria-nanocluster based therapy for Alzheimer's disease through the modulation of activated microglia and attenuation of amyloid-β deposition.基于二氧化铈纳米团簇的阿尔茨海默病治疗:通过调节活化的小胶质细胞和减轻淀粉样β蛋白沉积
Cell Biomater. 2025 Aug 6. doi: 10.1016/j.celbio.2025.100158.
2
Rapid mapping of spinal and supraspinal connectome self-targeting glucose-based carbon dots.基于葡萄糖的自靶向碳点对脊髓和脊髓上连接组的快速映射。
Nanoscale. 2025 Aug 26. doi: 10.1039/d5nr02670a.
3
Blood-brain barrier-penetrating Angiopep-2/Sirtuin 1 nanoparticles rescue sevoflurane neurotoxicity through multi-omics identified necroptosis pathways.
穿透血脑屏障的血管活性肠肽-2/沉默调节蛋白1纳米颗粒通过多组学鉴定的坏死性凋亡途径挽救七氟醚神经毒性。
J Nanobiotechnology. 2025 Aug 21;23(1):579. doi: 10.1186/s12951-025-03639-w.
4
Nanotherapies based on bacterial metabolism: Mechanisms, design and application.基于细菌代谢的纳米疗法:机制、设计与应用。
Mater Today Bio. 2025 Jul 18;34:102117. doi: 10.1016/j.mtbio.2025.102117. eCollection 2025 Oct.
5
Microglial Modulation as a Therapeutic Avenue for Perioperative Neurocognitive Disorders: Unveiling Pathophysiological Mechanisms and Clinical Implications.小胶质细胞调节作为围手术期神经认知障碍的治疗途径:揭示病理生理机制和临床意义
CNS Neurosci Ther. 2025 Jul;31(7):e70481. doi: 10.1111/cns.70481.
6
Breaking barriers: exploring blood-brain barrier crossing mechanisms with nanomedicine for effective glioma treatment.突破障碍:利用纳米医学探索血脑屏障穿越机制以实现有效的胶质瘤治疗。
3 Biotech. 2025 Jul;15(7):213. doi: 10.1007/s13205-025-04378-3. Epub 2025 Jun 13.
7
Multifunctional natural chlorogenic acid based nanocarrier for Alzheimer's disease treatment.用于治疗阿尔茨海默病的多功能天然绿原酸基纳米载体
Mater Today Bio. 2025 May 8;32:101841. doi: 10.1016/j.mtbio.2025.101841. eCollection 2025 Jun.
8
Nanocarrier-based targeted drug delivery for Alzheimer's disease: addressing neuroinflammation and enhancing clinical translation.基于纳米载体的阿尔茨海默病靶向药物递送:应对神经炎症并加强临床转化
Front Pharmacol. 2025 May 14;16:1591438. doi: 10.3389/fphar.2025.1591438. eCollection 2025.
9
Targeting the chemokine-microglia nexus: A novel strategy for modulating neuroinflammation in Alzheimer's disease.靶向趋化因子-小胶质细胞轴:一种调节阿尔茨海默病神经炎症的新策略。
J Alzheimers Dis Rep. 2025 May 2;9:25424823251326044. doi: 10.1177/25424823251326044. eCollection 2025 Jan-Dec.
10
Engineered nanoparticles for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的工程纳米颗粒。
Front Pharmacol. 2025 Apr 3;16:1510798. doi: 10.3389/fphar.2025.1510798. eCollection 2025.